You're signed outSign in or to get full access.
BML Capital Management, LLC
BML Capital Management, LLC is a hedge fund manager headquartered in Zionsville, Indiana, United States. The firm is the managing member and sole general partner of BML Investment Partners, L.P., a Delaware limited partnership. BML Capital Management primarily serves pooled investment vehicles and institutional clients, managing a concentrated portfolio of public equities. The firm has a small team, commonly with less than 10 employees, and was founded in the early 2010s. BML Capital Management is known for fundamental research-driven investing with a focus on healthcare and biotechnology sectors.
Investment Strategy
BML Capital Management follows an opportunistic, research-intensive investment approach focusing on U.S. public equities, with a particular emphasis on the healthcare and biotechnology industries. Their strategy involves concentrated positions in select small- and mid-cap companies where the investment team identifies significant mispricings or catalysts. The firm employs deep fundamental analysis and seeks to take advantage of both long and short opportunities as part of an absolute return strategy.
Latest 13F Filing Activity
BML Capital Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 23 equity positions and 1 options positions with a total 13F market value of $132M. The fund increased holdings in Third Harmonic Bio Inc., Atea Pharmaceuticals Inc., Instil Bio Inc. among other positions. BML Capital Management, LLC reduced exposure to An2 Therapeutics Inc., Adverum Biotechnologies Inc., Whitehawk Therapeutics Inc. among others.
Top Holdings
Equity Positions (23)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A AVIR | ATEA PHARMACEUTICALS INC | 20.73% | $27.4M | 7,609,812 | $3.33 | $3.60 | +$4.6M |
T THRD | THIRD HARMONIC BIO INC | 15.71% | $20.8M | 3,824,417 | $3.47 | $5.43 | +$7.5M |
A ACRS | ACLARIS THERAPEUTICS INC | 15.31% | $20.2M | 14,250,000 | $1.21 | $1.42 | -$1.6M |
T TIL | INSTIL BIO INC | 8.43% | $11.1M | 534,899 | $14.06 | $20.83 | +$3.9M |
E EPIX | ESSA PHARMA INC | 5.43% | $7.2M | 4,221,546 | $1.79 | $1.70 | +$506.6K |
Options Positions (1)
| Ticker | Security | Action | Type | Notional Value | Contracts | Underlying Price | Premium Paid | Change (Contracts) | Change (Value) |
|---|---|---|---|---|---|---|---|---|---|
T TSLA | TESLA INC | New | Put | $1.7M | 2 | $317.66 | $317.66 | +2 | +$1.7M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more